Cargando…
A critical assessment of SELDI-TOF-MS for biomarker discovery in serum and tissue of patients with an ovarian mass
BACKGROUND: Less than 25% of patients with a pelvic mass who are presented to a gynecologist will eventually be diagnosed with epithelial ovarian cancer. Since there is no reliable test to differentiate between different ovarian tumors, accurate classification could facilitate adequate referral to a...
Autores principales: | Wegdam, Wouter, Moerland, Perry D, Meijer, Danielle, de Jong, Shreyas M, Hoefsloot, Huub C J, Kenter, Gemma G, Buist, Marrije R, Aerts, Johannes MF G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494530/ https://www.ncbi.nlm.nih.gov/pubmed/22824475 http://dx.doi.org/10.1186/1477-5956-10-45 |
Ejemplares similares
-
Label-Free LC-MS(e) in Tissue and Serum Reveals Protein Networks Underlying Differences between Benign and Malignant Serous Ovarian Tumors
por: Wegdam, Wouter, et al.
Publicado: (2014) -
Classification-based comparison of pre-processing methods for interpretation of mass spectrometry generated clinical datasets
por: Wegdam, Wouter, et al.
Publicado: (2009) -
Challenges for Biomarker Discovery in Body Fluids Using SELDI-TOF-MS
por: De Bock, Muriel, et al.
Publicado: (2010) -
The Application of SELDI-TOF-MS in Clinical Diagnosis of Cancers
por: Liu, Chibo
Publicado: (2011) -
Reproducible Cancer Biomarker Discovery in SELDI-TOF MS Using Different Pre-Processing Algorithms
por: Zou, Jinfeng, et al.
Publicado: (2011)